The aspirin resistance controversy: clinical entity or platelet heterogeneity?
- PMID: 16801473
- DOI: 10.1161/CIRCULATIONAHA.106.635847
The aspirin resistance controversy: clinical entity or platelet heterogeneity?
Comment on
-
Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.Circulation. 2006 Jun 27;113(25):2888-96. doi: 10.1161/CIRCULATIONAHA.105.596627. Epub 2006 Jun 19. Circulation. 2006. PMID: 16785341
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
